(Q46982765)
Statements
Use of pharmacogenetics in bioequivalence studies to reduce sample size: an example with mirtazapine and CYP2D6 (English)
N González-Vacarezza
E Peñas-Lledó
F Estévez-Carrizo
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference